SOLIGENIX, INC. — Director's Dealing 2007

Aug 29, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2007-08-29

Reporting Person: MYRIANTHOPOULOS EVAN (Director, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-08-29	Common Stock	P	70000	$0.3096	Acquired	224780	Direct